Portfolio Flip Cards (portfolio_item_view)
KSM/API and FDF
Medical Sterilization
PPE Capacity and Raw Materials
Testing Capacity and Raw Materials
Therapeutics Supplies and Raw Materials
Location: Menlo Park, CA (R&D) and Lafayette, IN (Mfg.)
Product:Oripavine and Thebaine
Description of Project: Modernize fermentation capacities to leverage bioengineering and computational biology to produce one (1) key starting material used to produce all priority essential reversal agents.
Unique Impact: Using Bio Synthetic manufacturing to end our drug shortages and reduce reliance on Petro Chemical drug manufacturing
Base Award Amount: $11,958,014
Year Awarded: December 2024
Projected Drug Master File (DMF) Filing Date:December 2026.
Category: KSM/API and FDF